Synopsys and OpenAI announced a revenue-sharing partnership Wednesday to develop GPT-Synopsys, an AI model trained specifically for chip-design work, while the Federal Trade Commission reportedly prepares a broad investigation into OpenAI, Anthropic, and other AI labs over consumer protection concerns.
The collaboration tests whether artificial intelligence can deliver measurable value in a highly technical field. Synopsys makes software used to design computing chips, and it will charge OpenAI a training subscription fee. When Synopsys customers deploy the model, the companies will split revenue based on how effectively it improves chip design performance.
The Deal's Structure
The partnership has several layers. OpenAI's model will learn to use Synopsys software to help engineers navigate design trade-offs and optimizations. “To be able to shave off weeks, months from the design process and to bring more chips to the world,” OpenAI co-founder Greg Brockman said in a video announcing the deal. Synopsys CEO Sassine Ghazi told Reuters that traditional computing techniques will verify the AI's output before any chip reaches production. “The model needs these guardrails in order to check the physics. The need for validating with the highest level of fidelity, what we call sign-off or ground truth, is essential.”
Ghazi rejected concerns that the partnership threatens Synopsys's core business. “The deal will not be cannibalizing our business,” he told investors. “It will be an upside to our business given we're delivering more value to the customer.” Investors welcomed the news. Synopsys shares rose as much as 7% after the announcement.
The company also raised its fiscal 2027 revenue guidance to 15%, well above analyst estimates of 11.19% growth, according to LSEG data. Synopsys made the projection at its investor summit on the same day it announced the deal.
Regulatory Scrutiny Intensifies
As Synopsys and OpenAI celebrate their partnership, regulators are tightening their grip on the broader AI sector. The New York Post reported Wednesday that the FTC plans to issue formal demands—essentially subpoenas—requiring AI companies to submit information. Administration officials provided the report’s sourcing. The FTC, Anthropic, and OpenAI haven't responded to Reuters' requests for comment, and Reuters couldn't verify the report independently.
The timing points to a widening split in how government treats AI development. Synopsys's deal with OpenAI, on one hand, shows private enterprise identifying a genuine market need and addressing it through competition and partnership. The model enhances human capability rather than replacing it entirely. Verification remains mandatory. The companies absorb the risk if things go wrong.
Federal regulators, on the other hand, are moving ahead with probes into these same companies. The FTC's investigation suggests policymakers remain unconvinced that market forces and existing consumer-protection law adequately address AI risks. That view could lead to significant new regulatory burdens on the industry.
Ghazi's focus on guardrails and validation highlights a key tension: the AI industry has powerful incentives to regulate itself because failure can be catastrophic. A faulty chip design wastes millions in development and manufacturing. But regulators may not accept these market-based safeguards.
Why This Matters:
The Synopsys-OpenAI deal shows how artificial intelligence can generate private-sector value through genuine innovation rather than regulatory mandates or government subsidy. Revenue-sharing arrangements align incentives and create natural accountability: if the model fails to deliver, both companies lose money. Government-directed AI development, by contrast, often lacks comparable performance pressure. Meanwhile, the FTC probe signals Washington's instinct to expand regulatory authority over emerging technologies. History suggests formal government investigation typically brings compliance costs, reporting requirements, and restrictions that benefit incumbent firms while slowing innovation. Whether AI develops primarily through market competition or regulatory decree will shape whether American companies maintain their technological lead or cede ground to less-regulated international competitors.